title: Does interferon-a exert an anti-leukemic effect by enhancing cell mediated immunity in chronic myeloid leukemia?
authors.forename: P
authors.initials: P
authors.lastname: Muretto
authors.forename: S
authors.initials: S
authors.lastname: Tomassoni
authors.forename: M P
authors.initials: MP
authors.lastname: Staccioli
authors.forename: L
authors.initials: L
authors.lastname: Tabellini
authors.forename: F
authors.initials: F
authors.lastname: D'Adamo
authors.forename: C
authors.initials: C
authors.lastname: Delfini
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000276:immunology* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D016898:Interferon-alpha / Q000276:immunology* / Q000494:pharmacology / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000276:immunology*; D008875:Middle Aged; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha